Engineering disease analyte response in peptide self-assembly
A need to enhance the precision and specificity of therapeutic nanocarriers inspires the
development of advanced nanomaterials capable of sensing and responding to disease …
development of advanced nanomaterials capable of sensing and responding to disease …
Research Progress in Hydrogels for Cartilage Organoids
X Li, S Sheng, G Li, Y Hu, F Zhou… - Advanced Healthcare …, 2024 - Wiley Online Library
The repair and regeneration of cartilage has always been a hot topic in medical research.
Cartilage organoids (CORGs) are special cartilage tissue created using tissue engineering …
Cartilage organoids (CORGs) are special cartilage tissue created using tissue engineering …
Glucose-driven droplet formation in complexes of a supramolecular peptide and therapeutic protein
Biology achieves remarkable function through processes arising from spontaneous or
transient liquid–liquid phase separation (LLPS) of proteins and other biomolecules. While …
transient liquid–liquid phase separation (LLPS) of proteins and other biomolecules. While …
Strain-Stiffening Mechanoresponse in Dynamic-Covalent Cellulose Hydrogels
RC Ollier, MJ Webber - Biomacromolecules, 2024 - ACS Publications
Mechanical stimuli such as strain, force, and pressure are pervasive within and beyond the
human body. Mechanoresponsive hydrogels have been engineered to undergo changes in …
human body. Mechanoresponsive hydrogels have been engineered to undergo changes in …
Chiral Self‐Assembly of a Pyrene‐Appended Glutamylalanine Dipeptide and Its Charge Transfer Complex: Fabrication of Magneto‐Responsive Hydrogels and …
P Ruidas, SK Dubey, SA Hafiz, J Mandal… - Macromolecular …, 2024 - Wiley Online Library
The formation of a robust, self‐healing hydrogel of a novel pyrene‐appended dipeptide, Py‐
E‐A (L‐Glutamic acid short as E; L‐Alanine short as A) is demonstrated. Detailed studies …
E‐A (L‐Glutamic acid short as E; L‐Alanine short as A) is demonstrated. Detailed studies …
Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System
Glucose‐responsive glucagon (GRG) therapeutics are a promising technology for reducing
the risk of severe hypoglycemia as a complication of diabetes mellitus. Herein, the …
the risk of severe hypoglycemia as a complication of diabetes mellitus. Herein, the …
Engineering a Pathway to Glucose-Responsive Therapeutics
MJ Webber - Diabetes, 2024 - Am Diabetes Assoc
In 2014, the American Diabetes Association instituted a novel funding paradigm to support
diabetes research through its Pathway to Stop Diabetes program. This program took a …
diabetes research through its Pathway to Stop Diabetes program. This program took a …
Analytical and drug delivery strategies for short peptides: From manufacturing to market
A Chawathe, V Ahire, K Luthra, B Patil, K Garkhal… - Analytical …, 2024 - Elsevier
In recent times, biopharmaceuticals have gained attention because of their tremendous
potential to benefit millions of patients globally by treating widespread diseases such as …
potential to benefit millions of patients globally by treating widespread diseases such as …